Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
triticum aestivum pollen extract
- Development stage
- Unknown
- Lead developer
- Asac Pharmaceutical Inmunology
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Percutaneous, Subcutaneous, Intradermal
01
Overview
Triticum aestivum pollen extract is an allergenic extract derived from the pollen of common wheat (*Triticum aestivum*), a member of the Gramineae (grass) family. Developed by ASAC Pharmaceutical Inmunology, S.A., it is utilized both as a diagnostic tool in allergy skin prick testing and as an investigational therapeutic agent for type I hypersensitivity reactions, including allergic rhinitis and allergic conjunctivitis caused by grass pollen. The extract acts on the IgE-mediated immune pathway, where it is used to assess sensitivity in patients or to induce immunological tolerance through allergen-specific immunotherapy. It has been studied in Phase 2 clinical trials for biological standardization to determine relative potency, diagnostic concentration, and sensitivity.
- Other names
- common wheat pollen extractwheat pollen extract
02
Targets
IgE (Immunoglobulin E)
Beyond the preview
Go deeper on triticum aestivum pollen extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on triticum aestivum pollen extract.